Results 121 to 130 of about 7,115 (197)

Air pollution, inhaled therapy and COPD exacerbations in Yunlin, Taiwan: a 2016-2024 single-centre retrospective cohort with environmental and carbon-footprint analyses. [PDF]

BMJ Open Respir Res
Chen CY, Huang LY, Cheng BW.
europepmc   +1 more source

Optimizing Fluticasone Propionate and Ciclesonide pMDI Delivery: The Protective Role of Valved Holding Chambers Against Inhalation Timing Errors. [PDF]

J Asthma Allergy
Csonka LL, Lehtimäki L, Csonka P.
europepmc   +1 more source

A Strategy to Reduce Out-of-User-Life Utilization and Waste of Expired Budesonide-Formoterol Pressurized Metered-Dose Inhalers in Mild Asthma. [PDF]

Ann Am Thorac Soc
Stein KR, Jost E, Barker AR, Simkovich SM, Goss CW, Agarwal M, Huffman MD, Sumino K, Pleasants R, Castro M, Reddel HK, Krings JG.   +11 more
europepmc   +1 more source

Carbon emissions from the increasing use of inhaled corticosteroid-LABA medications: a primary care used case from Singapore. [PDF]

NPJ Prim Care Respir Med
Tan NC, Koh YLE, Leow QHM, Aau WK, Ng DX.   +4 more
europepmc   +1 more source

Evaluation of Preliminary Bronchodilation Effect on Aerosol Delivery from a Dry Powder Inhaler for Patients with Chronic Obstructive Pulmonary Disease with Suboptimal Peak Inspiratory Flow Rate. [PDF]

Clin Pharmacokinet
Hassan MI, Laz NI, Madney YM, Abdelrahim MEA, Harb HS.   +4 more
europepmc   +1 more source

Inhaler identification: evaluating a potential screening method for adherence in chronic respiratory disease management. [PDF]

J Bras Pneumol
Gomes DS, Seixas C, Cravo J.
europepmc   +1 more source

Reinforced lignin-based polyurethane foams with improved heat-insulating performance by using cellulose fibers. [PDF]

RSC Adv
Yang C, Tian G, Wang C, Wang B, Zhang Y, Li Z, Zhuang J, Geng C, Wang Z.   +8 more
europepmc   +1 more source

Focus on pMDI and VHC; Past, Present, Future! [PDF]

Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2014
openaire   +1 more source

Outcomes and Usability of Formoterol-Budesonide Delivered Through Synchrobreathe^® in Patients With Chronic Obstructive Pulmonary Disease: The EMERGE Study. [PDF]

Drugs Real World Outcomes
Balamurugan S, Pophale H, Samariya U, Apte K, Singh S, Dhar R, Rajan S, Swarnakar R, Talwar D, Lopez M, Naik V, Sawant S, Chhowala S, Vaidya A, Gogtay J.   +14 more
europepmc   +1 more source

Environmentally friendly inhaler decision-making with personalized care in asthma and chronic obstructive pulmonary disease: a qualitative study. [PDF]

Explor Res Clin Soc Pharm
Visser CD, Sulaiman A, Bakr N, Guchelaar HJ, Teichert M.   +4 more
europepmc   +1 more source